iZafe Group

iZafe Group EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of iZafe Group (IZAFE B.ST) as of Nov 19, 2026 is -4.70. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -11.54 — a change of -59.29% (higher).

EV/FCF

-4.70

YoY

-59.29%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of iZafe Group is 2025 -4.70 . EV/FCF (Enterprise Value to Free Cash Flow) of iZafe Group was 2024 -11.54 . It decreases by -59.29% higher compared to the previous year.

The iZafe Group EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-6.47 SEK
Jan 1, 2019
-7.28 SEK
Jan 1, 2020
-5.23 SEK
Jan 1, 2021
-3.70 SEK
Jan 1, 2022
-5.83 SEK
Jan 1, 2023
-10.63 SEK
Jan 1, 2024
-11.54 SEK
Jan 1, 2025
-4.70 SEK
The iZafe Group EV/FCF history
YEAREV/FCFYoY
-4.70-59.29%
-11.54+8.59%
-10.63+82.14%
-5.83+57.75%
-3.70-29.22%
-5.23-28.23%
-7.28+12.47%
-6.47-53.71%
-13.98-43.95%
-24.95-68.00%
-77.96-51.38%
-160.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iZafe Group stock

EV/FCF (Enterprise Value to Free Cash Flow) of iZafe Group is -4.70 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of iZafe Group changed from -11.54 to -4.70, representing a -59.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) iZafe Group since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s iZafe Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — iZafe Group

All Key Metrics — iZafe Group